6V6L
Co-structure of human glycogen synthase kinase beta with 1-(6-((2-((6-amino-5-nitropyridin-2-yl)amino)ethyl)amino)-2-(2,4-dichlorophenyl)pyridin-3-yl)-4-methylpiperazin-2-one
6V6L の概要
| エントリーDOI | 10.2210/pdb6v6l/pdb |
| 分子名称 | Glycogen synthase kinase-3 beta, 1-(6-((2-((6-amino-5-nitropyridin-2-yl)amino)ethyl)amino)-2-(2,4-dichlorophenyl)pyridin-3-yl)-4-methylpiperazin-2-one, PHOSPHATE ION, ... (4 entities in total) |
| 機能のキーワード | kinase, transferase |
| 由来する生物種 | Homo sapiens (Human) |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 47507.56 |
| 構造登録者 | |
| 主引用文献 | Ramurthy, S.,Pfister, K.B.,Boyce, R.S.,Brown, S.P.,Costales, A.Q.,Desai, M.C.,Fang, E.,Levine, B.H.,Ng, S.C.,Nuss, J.M.,Ring, D.B.,Shafer, C.M.,Shu, W.,Subramanian, S.,Wagman, A.S.,Wang, H.,Bussiere, D.E. Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors. Bioorg.Med.Chem.Lett., 30:126930-126930, 2020 Cited by PubMed Abstract: Glycogen synthase kinase-3 plays an essential role in multiple biochemical pathways in the cell, particularly in regards to energy regulation. As such, Glycogen synthase kinase-3 is an attractive target for pharmacological intervention in a variety of disease states, particularly non-insulin dependent diabetes mellitus. However, due to homology with other crucial kinases, such as the cyclin-dependent protein kinase CDC2, developing compounds that are both potent and selective is challenging. A novel series of derivatives of 5-nitro-N2-(2-(pyridine-2ylamino)ethyl)pyridine-2,6-diamine were synthesized and have been shown to potently inhibit glycogen synthase kinase-3 (GSK3). Potency in the low nanomolar range was obtained along with remarkable selectivity. The compounds activate glycogen synthase in insulin receptor-expressing CHO-IR cells and in primary rat hepatocytes, and have acceptable pharmacokinetics and pharmacodynamics to allow for oral dosing. The X-ray co-crystal structure of human GSK3-β in complex with compound 2 is reported and provides insights into the structural determinants of the series responsible for its potency and selectivity. PubMed: 31926786DOI: 10.1016/j.bmcl.2019.126930 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.19 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






